These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35790938)

  • 1. Cross-cultural validation of the Chinese version of the EmPHasis-10 questionnaire in connective tissue disease patients with pulmonary arterial hypertension and its relationship with risk stratification.
    Shi Y; Dong X; Hu X; Weng L; Liu Y; Lai J; Tian Z; Zhao J; Li M; Peng J; Wang Q; Zeng X
    BMC Pulm Med; 2022 Jul; 22(1):264. PubMed ID: 35790938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life in ambulatory pulmonary arterial hypertension in connective tissue diseases and its relationship with risk stratification.
    Shi Y; Meng Y; Dong X; Liu Y; Liu Y; Lai J; Tian Z; Zhao J; Peng J; Wang Q; Li M; Zeng X
    Pulm Circ; 2021; 11(3):20458940211029899. PubMed ID: 34290858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simplified risk stratification for pulmonary arterial hypertension associated with connective tissue disease.
    Li X; Sun X; Huang Y; Wang Y; Yang X; Wang J; Zhang N; Gu L; Zhang M; Wang Q
    Clin Rheumatol; 2019 Dec; 38(12):3619-3626. PubMed ID: 31385084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multicentre study.
    Lewis RA; Armstrong I; Bergbaum C; Brewis MJ; Cannon J; Charalampopoulos A; Church AC; Coghlan JG; Davies RJ; Dimopoulos K; Elliot C; Gibbs JSR; Gin-Sing W; Haji G; Hameed AG; Howard LS; Johnson MK; Kempny A; Kiely DG; Lo Giudice F; McCabe C; Peacock AJ; Peleyeju O; Pepke-Zaba J; Polwarth G; Price L; Sabroe I; Schreiber BE; Sheares K; Taboada D; Thompson AAR; Toshner MR; Wanjiku I; Wort SJ; Yorke J; Condliffe R
    Eur Respir J; 2021 Feb; 57(2):. PubMed ID: 32631835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum uric acid is associated with disease severity and may predict clinical outcome in patients of pulmonary arterial hypertension secondary to connective tissue disease in Chinese: a single-center retrospective study.
    Wang J; Wang Y; Li X; Huang Y; Sun X; Wang Q; Zhang M
    BMC Pulm Med; 2020 Oct; 20(1):272. PubMed ID: 33076877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of pulmonary arterial pressure in patients with connective tissue disease-associated pulmonary arterial hypertension by myocardial perfusion imaging.
    Wang Z; Li J; Wang X; Liu M; Liao M; Zhang C; Shang X
    Ann Noninvasive Electrocardiol; 2022 Mar; 27(2):e12927. PubMed ID: 34908208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recommendations for the diagnosis and treatment of connective tissue disease associated pulmonary arterial hypertension in China].
    Zhang X; Zhao JL; Ding F; Yang J; Wang J; Zeng XF; Zhao Y
    Zhonghua Nei Ke Za Zhi; 2022 Nov; 61(11):1206-1216. PubMed ID: 36323561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [2020 Chinese expert-based consensus statement regarding the diagnosis and treatment of connective tissue disease associated pulmonary arterial hypertension].
    ; ;
    Zhonghua Nei Ke Za Zhi; 2021 May; 60(5):406-420. PubMed ID: 33906271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment strategy of connective tissue disease associated pulmonary arterial hypertension: Evolving into the future.
    Zhao J; Wang Q; Deng X; Qian J; Tian Z; Liu Y; Li M; Zeng X
    Pharmacol Ther; 2022 Nov; 239():108192. PubMed ID: 35461923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Biomarkers in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
    Moccaldi B; De Michieli L; Binda M; Famoso G; Depascale R; Perazzolo Marra M; Doria A; Zanatta E
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Pulmonary Function Test for Pulmonary Arterial Hypertension in Patients with Connective Tissue Disease.
    Xiong J; Li J; Huang Y; Yang F; Wu R
    Dis Markers; 2022; 2022():6066291. PubMed ID: 36212174
    [No Abstract]   [Full Text] [Related]  

  • 12. Diversity of hemodynamic types in connective tissue disease associated pulmonary hypertension: more than a subgroup of pulmonary arterial hypertension.
    Dong X; Shi Y; Xia Y; Zhang X; Qian J; Zhao J; Peng J; Wang Q; Weng L; Li M; Du B; Zeng X
    BMC Pulm Med; 2022 Aug; 22(1):295. PubMed ID: 35909128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation in pulmonary arterial hypertension - association with mortality, healthcare utilization, and quality of life: The Pulmonary Hypertension Association Registry (PHAR).
    Garry JD; Kolaitis NA; Kronmal R; Thenappan T; Hemnes A; Grinnan D; Bull T; Chakinala MM; Horn E; Simon MA; De Marco T;
    J Heart Lung Transplant; 2022 Dec; 41(12):1808-1818. PubMed ID: 36150996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Right atrial function for the prediction of prognosis in connective tissue disease-associated pulmonary arterial hypertension: a study with two-dimensional speckle tracking.
    Bai Y; Yang J; Liu J; Ning H; Zhang R
    Int J Cardiovasc Imaging; 2019 Sep; 35(9):1637-1649. PubMed ID: 31037473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The short-term role of corticosteroid therapy for pulmonary arterial hypertension associated with connective tissue diseases: report of five cases and a literature review.
    Kato M; Kataoka H; Odani T; Fujieda Y; Otomo K; Oku K; Horita T; Yasuda S; Atsumi T; Ohira H; Tsujino I; Nishimura M; Koike T
    Lupus; 2011 Oct; 20(10):1047-56. PubMed ID: 21676917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of ambrisentan in Chinese patients with connective tissue disease-pulmonary arterial hypertension: a post-hoc analysis.
    Li M; Jing ZC; Li Y; Huo Y; Yu Z; Zhang G; Zhu P; Liu J; Ji Q; Wu B; Zhong J; Wang P; Zhu W; Zeng X
    BMC Cardiovasc Disord; 2020 Jul; 20(1):339. PubMed ID: 32680480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic Cell Subsets and Effector Function in Idiopathic and Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
    van Uden D; Boomars K; Kool M
    Front Immunol; 2019; 10():11. PubMed ID: 30723471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic markers and treatment of connective tissue disease-associated pulmonary arterial hypertension: current recommendations and recent advances.
    Kato M; Sugimoto A; Atsumi T
    Expert Rev Clin Immunol; 2020 Oct; 16(10):993-1004. PubMed ID: 32975145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of pulmonary arterial hypertension in connective tissue disease.
    Grünig E
    Drugs; 2012 May; 72(8):1039-56. PubMed ID: 22621693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nailfold videocapillaroscopic changes in patients with pulmonary arterial hypertension associated with connective tissue diseases.
    Arvanitaki A; Giannakoulas G; Triantafyllidou E; Pagkopoulou E; Boutou A; Garyfallos A; Karvounis H; Dimitroulas T
    Rheumatol Int; 2021 Jul; 41(7):1289-1298. PubMed ID: 33978819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.